Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparison

References

• Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. JCO. 2003;21:2719–2725.
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196:305–315.
   PubMed Web of Science ®Google Scholar
• Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203.
   PubMed Web of Science ®Google Scholar
• Jebsen NL, Trovik CS, Bauer HCF, et al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys. 2008;71:1196–1203.
   PubMed Web of Science ®Google Scholar
• Koshy M, Rich SE, Mohiuddin MM. Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: a SEER analysis. Int J Radiat Oncol Biol Phys. 2010;77:203–209.
   PubMed Web of Science ®Google Scholar
• Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol. 2016;17:966–975.
   PubMed Web of Science ®Google Scholar
• Edmonson JH, Ryan LM, Blum RH, et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993;11:1269–1275.
   PubMed Web of Science ®Google Scholar
• Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–581.
   PubMed Web of Science ®Google Scholar
• Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. JCO. 2001;19:1238–1247.
   PubMed Web of Science ®Google Scholar
• Hartmann JT, Schütte J. Neoadjuvante Chemotherapie des lokalisierten Weichteilsarkoms. Onkologe. 2009;15:389–397.
   Web of Science ®Google Scholar
• Italiano A, Delva F, Mathoulin-Pelissier S, et al. Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database. Ann. Oncol. 2010;21:2436–2441.
   PubMed Web of Science ®Google Scholar
• Demetri GD, Antonia S, Benjamin RS, et al. Soft tissue sarcoma. J Natl Compr Canc Netw. 2010;8:630–674.
   PubMed Web of Science ®Google Scholar
• Pisters PWT, Ballo MT, Patel SR. Preoperative chemoradiation treatment strategies for localized sarcoma. Ann Surg Oncol. 2002;9:535–542.
   PubMed Web of Science ®Google Scholar
• Curtis KK, Ashman JB, Beauchamp CP, et al. Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities. Radiat Oncol. 2011;6:91.
   PubMed Web of Science ®Google Scholar
• Issels RD, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010;11:561–570.
   PubMed Web of Science ®Google Scholar
• Eckert F, Gani C, Kluba T, et al. Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcomas. Strahlenther Onkol. 2013;189:482–485.
   PubMed Web of Science ®Google Scholar
• Look Hong NJ, Hornicek FJ, Harmon DC, et al. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study. Eur J Cancer. 2013;49:875–883.
   PubMed Web of Science ®Google Scholar
• Kraybill WG, Harris J, Spiro IJ, et al. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. JCO. 2006;24:619–625.
   PubMed Web of Science ®Google Scholar
• Palassini E, Ferrari S, Verderio P, et al. Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: three versus five cycles of full-dose Epirubicin Plus Ifosfamide. JCO. 2015;33:3628–3634.
   PubMed Web of Science ®Google Scholar
• Haas RLM, Delaney TF, O'Sullivan B, et al. Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?. Int J Radiat Oncol Biol Phys. 2012;84:572–580.
   PubMed Web of Science ®Google Scholar
• Lagendijk JJ, Van Rhoon GC, Hornsleth SN, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia. 1998;14:125–133.
   PubMed Web of Science ®Google Scholar
• Bruggmoser G, Bauchowitz S, Canters R, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol. 2011;187:605–610.
   PubMed Web of Science ®Google Scholar
• Salzer-Kuntschik M, Delling G, Beron G, et al. Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80. J Cancer Res Clin Oncol. 1983;106(Suppl):21–24.
   PubMed Web of Science ®Google Scholar
• Andreou D, Werner M, Pink D, et al. Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma. Br J Cancer. 2015;112:455–460.
   PubMed Web of Science ®Google Scholar
• Kandel R, Coakley N, Werier J, et al. Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline. Curr Oncol. 2013;20:e247–2e254.
   PubMed Web of Science ®Google Scholar
• McKee MD, Liu DF, Brooks JJ, et al. The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol. 2004;85:68–76.
   PubMed Web of Science ®Google Scholar
• O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235–2241.
   PubMed Web of Science ®Google Scholar
• Davis AM, O’Sullivan B, Bell RS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. JCO. 2002;20:4472–4477.
   PubMed Web of Science ®Google Scholar
• Davis A, Osullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48–53.
   PubMed Web of Science ®Google Scholar
• Zagars GK, Ballo MT, Pisters PWT, et al. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 2003;56:482–488.
   PubMed Web of Science ®Google Scholar
• Jacobs AJ, Michels R, Stein J, et al. Improvement in overall survival from extremity soft tissue sarcoma over twenty years. Sarcoma. 2015;2015:279601.
   PubMedGoogle Scholar
• Eilber FC, Rosen G, Nelson SD, et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003;237:218–226.
   PubMed Web of Science ®Google Scholar
• Brennan MF, Antonescu CR, Moraco N, et al. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014;260:416–421. discussion 421–422.
   PubMed Web of Science ®Google Scholar
• MacNeill AJ, Miceli R, Strauss DC, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: a report from the Trans-Atlantic RPS Working Group. Cancer. 2017;123:1971–1978.
   PubMed Web of Science ®Google Scholar
• Gingrich AA, Bateni SB, Monjazeb AM, et al. Neoadjuvant radiotherapy is associated with R0 resection and improved survival for patients with extremity soft tissue sarcoma undergoing surgery: a national cancer database analysis. Ann Surg Oncol. 2017;24:3252–3263.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Ferrari S, Quagliuolo V, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017;18:812–822.
   PubMed Web of Science ®Google Scholar
• Fairweather M, Keung E, Raut CP. Neoadjuvant therapy for soft-tissue sarcomas. Oncology (Williston Park, N.Y.). 2016;30:99–106.
   PubMed Web of Science ®Google Scholar
• Issels RD, Lindner LH, Verweij J, et al. Neoadjuvant chemotherapy plus regional hyperthermia and long-term outcomes among patients with localized high-risk soft tissue sarcoma. JAMA Oncol. 2018;4:483–410.
   PubMed Web of Science ®Google Scholar
• Pfeffer MR, Teicher BA, Holden SA, et al. The interaction of cisplatin plus etoposide with radiation +/- hyperthermia. Int J Radiat Oncol Biol Phys. 1990;19:1439–1447.
   PubMed Web of Science ®Google Scholar
• Westermann AM, Wiedemann GJ, Jager E, et al. A systemic hyperthermia oncologic working group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma. Oncology. 2003;64:312–321.
   PubMed Web of Science ®Google Scholar
• Farry JK, Flombaum CD, Latcha S. Long term renal toxicity of ifosfamide in adult patients-5 year data. Eur J Cancer. 2012;48:1326–1331.
   PubMed Web of Science ®Google Scholar
• Brauer LP, Prieshof B, Wiedemann GJ, et al. Whole-body hyperthermia combined with ifosfamide and carboplatin causes hypotension and nephrotoxicity. J Cancer Res Clin Oncol. 1998;124:549–554.
   PubMed Web of Science ®Google Scholar
• Mahmoud O, Tunceroglu A, Chokshi R, et al. Overall survival advantage of chemotherapy and radiotherapy in the perioperative management of large extremity and trunk soft tissue sarcoma; a large database analysis. Radiother Oncol. 2017. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0167814017324805
   Google Scholar
• Jakob J, Hohenberger P. Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcoma. Cancer. 2016;122:2624–2632.
   PubMed Web of Science ®Google Scholar
• DeLaney TF, Spiro IJ, Suit HD, et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003;56:1117–1127.
   PubMed Web of Science ®Google Scholar
• Schaefer I-M, Hornick JL, Barysauskas CM, et al. Histologic appearance after preoperative radiation therapy for soft tissue sarcoma: assessment of the european organization for research and treatment of cancer-soft tissue and bone sarcoma group response score. Int J Radiat Oncol Biol Phys. 2017;98:375–383.
   PubMed Web of Science ®Google Scholar
• Stahl R, Wang T, Lindner LH, et al. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS). Int J Hyperthermia. 2009;25:289–298.
   PubMed Web of Science ®Google Scholar
• Canter RJ, Martinez SR, Tamurian RM, et al. Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma. Ann Surg Oncol. 2010;17:2578–2584.
   PubMed Web of Science ®Google Scholar
• Egawa S, Tsukiyama I, Kajiura Y, et al. Characteristics of the response of soft tissue sarcoma to hyperthermia: the correlation between temperature distribution, radiological examination and histology. Int J Hyperthermia. 1989;5:23–35.
   PubMed Web of Science ®Google Scholar